EFFECTOR THERAPEUTICS, INC. — Form D/A

EFFECTOR THERAPEUTICS, INC. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2014-08-14. The offering totals $57.0M, of which $21.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Carol G Gallagher, Pharm.D.DirectorSan Diego, CA
Simeon G GeorgeDirectorSan Diego, CA
Markus G GoebelDirectorSan Diego, CA
Ken G HaasDirectorSan Diego, CA
Laurence G LaskyDirectorSan Diego, CA
Jonathan G RootDirectorSan Diego, CA
Maha T KatabiDirectorBoston, MA
Denis W Patrick, Ph.D.DirectorSan Diego, CA
Stephen T Worland, Ph.D.DirectorSan Diego, CA
Stephen T Worland, Ph.D.Executive OfficerSan Diego, CA
John W SmitherDirectorSan Diego, CA
Stefan D Larson, Ph.D.DirectorSan Diego, CA
Alana D McNultyExecutive OfficerSan Diego, CA
David D Maki, J.D.DirectorSan Diego, CA
Jonathan D Root, M.D.DirectorSan Diego, CA
Kenneth J Haas, J.D.DirectorSan Diego, CA
Simeon J George, M.D.DirectorSan Diego, CA
Laurence T Lasky, Ph.D.DirectorSan Diego, CA
Jeremy D Barton, M.D.Executive OfficerSan Diego, CA
Maha D Katabi, Ph.D.DirectorSan Diego, CA
Markus J Goebel, M.D., Ph.D.DirectorSan Diego, CA
Elaine D Jones, Ph.D.DirectorSan Diego, CA
Ken T HaasDirectorSan Diego, CA
Simeon T GeorgeDirectorSan Diego, CA
Laurence T LaskyDirectorSan Diego, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2019-05-14D$21.8M$20.4M
2017-07-27D$38.6M$16.8M
2016-02-22D/A$56.0M$56.0M
2015-12-23D$45.0M$40.0M
2015-07-24D/A$57.0M$36.2M
2013-05-28D$46.4M$17.4M

More